J&J slashes third-quarter profit by $3 billion over proposed opioid deal
(Reuters) - Johnson & Johnson on Wednesday lowered its previously reported third-quarter profit by $3 billion (£2.33 billion) to account for a proposed opioid settlement payment.
(Reuters) - Johnson & Johnson
A framework settlement, announced on Monday, was hammered out by some drugmakers and distributors and attorneys general in North Carolina, Pennsylvania, Tennessee and Texas. The proposed deal will need broad support among all the state attorneys general and local governments that have sued the companies over the opioid crisis.
J&J, which is facing thousands of lawsuits over a variety of products, lowered its reported profit to $1.8 billion, or 66 cents per share, from $4.8 billion, or $1.81 per share, and said there was no impact to its adjusted earnings numbers.
The company said it could not predict when or if the opioid deal would be finalized.
"(J&J) has to disclose it now - and take the accounting hit. Later they can come back and adjust the impact on an actual payment/settlement on their goodwill when the actual cost of the settlement comes into focus," Brian Quinn at Boston College Law School said.
Reuters reported last week citing sources that drug distributors McKesson Corp
The drug industry faces roughly 2,600 lawsuits brought by state and local governments, hospitals and other entities seeking to hold drugmakers and distributors responsible for the toll of opioid abuse.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Saumyadeb Chakrabarty)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Chuck Mikolajczak NEW YORK (Reuters) - A gauge of global stocks hit a record and oil prices jumped on Monday as the newest positive data for a potential COVID-19 vaccine and signs of economic recovery in Asia boosted sentiment. U.S. stocks advanced, with the Dow Industrials setting a record as it neared the 30,000 mark for the first time, after pharma company Moderna said its prospective vaccine was 94.5% effective in preventing the illness, which has crushed economies across the globe
By Anirban Sen and Joshua Franklin (Reuters) - Airbnb Inc's initial public offering (IPO) registration showed on Monday that the home rental startup turned a profit in the third quarter despite the COVID-19 pandemic, as it gears up for one of the most anticipated stock market debuts in recent years. The filing, published ahead of Airbnb's anticipated stock market debut in December, showed a dramatic recovery in its fortunes, after the coronavirus outbreak dragged down its core home rental business during the first half of the year. The slump forced it to lay off 25% of its workforce in May, suspend marketing activities for the year and seek $2 billion (£1.5 billion) emergency funding from investors, including Silver Lake and Sixth Street Partners, at a valuation of $18 billion
By David Lawder WASHINGTON (Reuters) - U.S. President-elect Joe Biden said on Monday the United States needed to negotiate with allies to set global trading rules to counter China's growing influence but declined to say whether he would join a new China-backed Asian trade pact signed on Sunday.